Ruthenium‐Containing Linear Helicates and Mesocates with Tuneable p53‐Selective Cytotoxicity in Colorectal Cancer Cells
- 4 June 2018
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 130 (31) , 9947-9952
Abstract
The ligands L1 and L2 both form separable dinuclear double‐stranded helicate and mesocate complexes with RuII. In contrast to clinically approved platinates, the helicate isomer of [Ru2(L1)2]4+ was preferentially cytotoxic to isogenic cells (HCT116 p53−/−), which lack the critical tumour suppressor gene. The mesocate isomer shows the reverse selectivity, with the achiral isomer being preferentially cytotoxic towards HCT116 p53+/+. Other structurally similar RuII‐containing dinuclear complexes showed very little cytotoxic activity. This study demonstrates that alterations in ligand or isomer can have profound effects on cytotoxicity towards cancer cells of different p53 status and suggests that selectivity can be “tuned” to either genotype. In the search for compounds that can target difficult‐to‐treat tumours that lack the p53 tumour suppressor gene, [Ru2(L1)2]4+ is a promising compound for further development.Keywords
This publication has 59 references indexed in Scilit:
- A triple helix of double helicates: three hierarchical levels of self-assembly in a single structureChemical Communications, 2012
- Anion-Dependent Formation of Helicates versus Mesocates of Triple-Stranded M2L3 (M = Fe2+, Cu2+) ComplexesInorganic Chemistry, 2011
- Rational Design of a Ternary Supramolecular System: Self-Assembly of Pentanuclear Lanthanide HelicatesJournal of the American Chemical Society, 2011
- ATR mediates cisplatin resistance in a p53 genotype-specific mannerOncogene, 2011
- SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53PLOS ONE, 2010
- Antimicrobial activity of an iron triple helicateInternational Journal of Antimicrobial Agents, 2009
- Supramolecular Iron Cylinder with Unprecedented DNA Binding Is a Potent Cytostatic and Apoptotic Agent without Exhibiting GenotoxicityChemistry & Biology, 2008
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994